Literature DB >> 1622416

A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus.

K S Ginsburg1, E A Wright, M G Larson, A H Fossel, M Albert, P H Schur, M H Liang.   

Abstract

OBJECTIVE: To investigate the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus (SLE).
METHODS: Randomly selected, ambulatory patients with SLE (n = 49) or with rheumatoid arthritis (RA) (n = 40) completed neuropsychological tests. These included Associate Learning, Switching Attention, Continuous Performance, Associate Recall, Hand-Eye Coordination, Pattern Comparison, Pattern Memory, the Stroop Color and Word Test, and the Symptoms Checklist-90R. Results were evaluated by multiple linear regression analysis.
RESULTS: SLE patients had poorer performance than RA patients on the test of attention (P = 0.002) and tests of visuospatial ability (P = 0.03) and P = 0.04), independent of age, education, or steroid use. The conservative level of statistical significance, adjusting for multiple comparisons, was 0.005. SLE patients reported more symptoms of cognitive difficulty.
CONCLUSION: Cognitive dysfunction is common in ambulatory SLE patients as measured by standardized tests and is a cause of distress and impaired functioning. Self-reported cognitive difficulty appears to correlate with objective performance.

Entities:  

Mesh:

Year:  1992        PMID: 1622416     DOI: 10.1002/art.1780350711

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  23 in total

1.  Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration.

Authors:  Meggan Mackay; Mathew P Bussa; Cynthia Aranow; Aziz M Uluğ; Bruce T Volpe; Patricio T Huerta; Miklos Argyelan; Arthur Mandel; Joy Hirsch; Betty Diamond; David Eidelberg
Journal:  Mol Med       Date:  2011-09-21       Impact factor: 6.354

2.  Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

Authors:  Czeslawa Kowal; Lorraine A Degiorgio; Ji Y Lee; Mark A Edgar; Patricio T Huerta; Bruce T Volpe; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-14       Impact factor: 11.205

Review 3.  Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment.

Authors:  Melanie J Harrison; Lisa D Ravdin
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

4.  Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.

Authors:  Elizabeth Kozora; Sterling G West; Steven F Maier; Christopher M Filley; David B Arciniegas; Mark Brown; David Miller; Alex Grimm; Lening Zhang
Journal:  J Neurol Sci       Date:  2010-05-23       Impact factor: 3.181

Review 5.  Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

Authors:  R A Asherson; S D Denburg; J A Denburg; R M Carbotte; N Futrell
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

6.  Neuropsychological analysis in patients with systemic lupus erythematosus: a case control study.

Authors:  P J Modrego; J P Venegas; M S Cuenca; R S Moreno; A J Delgado
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

7.  A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus.

Authors:  Gail S Ross; Frank Zelko; Marisa Klein-Gitelman; Deborah M Levy; Eyal Muscal; Laura E Schanberg; Kelly Anthony; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-07       Impact factor: 4.794

Review 8.  Neurocognitive impairment in children and adolescents with systemic lupus erythematosus.

Authors:  Deborah M Levy; Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

9.  Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus.

Authors:  J G Hanly; M B Urowitz; L Su; S C Bae; C Gordon; D J Wallace; A Clarke; S Bernatsky; D Isenberg; A Rahman; G S Alarcón; D D Gladman; P R Fortin; J Sanchez-Guerrero; J Romero-Diaz; J T Merrill; E Ginzler; I N Bruce; K Steinsson; M Khamashta; M Petri; S Manzi; M A Dooley; R Ramsey-Goldman; R Van Vollenhoven; O Nived; G Sturfelt; C Aranow; K Kalunian; M Ramos-Casals; A Zoma; J Douglas; K Thompson; V Farewell
Journal:  Ann Rheum Dis       Date:  2009-04-08       Impact factor: 19.103

10.  Central nervous system lupus: concomitant occurrence of myelopathy and cognitive dysfunction.

Authors:  H D Stahl; T H Ettlin; A Plohmann; E W Radü; J Müller-Brand; U Steiger; A Tyndall
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.